Cargando…

Aminostyrylbenzofuran Directly Reduces Oligomeric Amyloid-β and Reverses Cognitive Deficits in Alzheimer Transgenic Mice

Alzheimer's disease is an irreversible neurodegenerative disorder that is characterized by the abnormal aggregation of amyloid-β into neurotoxic oligomers and plaques. Although many disease-modifying molecules are currently in Alzheimer clinical trials, a small molecule that inhibits amyloid-β...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Sang-Hyun, Kim, YoungSoo, Kim, Hye Yun, Kim, Young Hoon, Kim, Maeng Sup, Kong, Jae Yang, Lee, Mun-Han, Kim, Dong Jin, Ahn, Young Gil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997483/ https://www.ncbi.nlm.nih.gov/pubmed/24760018 http://dx.doi.org/10.1371/journal.pone.0095733

Ejemplares similares

Carprofen alleviates Alzheimer-like phenotypes of 5XFAD transgenic mice by targeting the pathological hallmarks induced by amyloid-β aggregation
por: Lee, Donghee, et al.
Publicado: (2023)

Fluorescent indolizine derivative YI-13 detects amyloid-β monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model
por: Kim, DaWon, et al.
Publicado: (2020)

Correction: Fluorescent indolizine derivative YI-13 detects amyloid-β monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model
por: Kim, DaWon, et al.
Publicado: (2021)

Quinacrine directly dissociates amyloid plaques in the brain of 5XFAD transgenic mouse model of Alzheimer’s disease
por: Park, Sohui, et al.
Publicado: (2021)

Aryloxypropanolamine targets amyloid aggregates and reverses Alzheimer-like phenotypes in Alzheimer mouse models
por: Lee, Hee Yang, et al.
Publicado: (2022)

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
por: Youn, Young Chul, et al.
Publicado: (2019)

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
por: Lee, Jinny Claire, et al.
Publicado: (2019)

EPPS rescues hippocampus-dependent cognitive deficits in APP/PS1 mice by disaggregation of amyloid-β oligomers and plaques
por: Kim, Hye Yun, et al.
Publicado: (2015)

Corrigendum: EPPS rescues hippocampus-dependent cognitive deficits in APP/PS1 mice by disaggregation of amyloid-β oligomers and plaques
por: Kim, Hye Yun, et al.
Publicado: (2016)

Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis
por: Pyun, Jung-Min, et al.
Publicado: (2023)

Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
por: Yang, YoungSoon, et al.
Publicado: (2018)

Correlations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse model
por: Cho, Soo Min, et al.
Publicado: (2014)

Thioflavin-positive tau aggregates complicating quantification of amyloid plaques in the brain of 5XFAD transgenic mouse model
por: Shin, Jisu, et al.
Publicado: (2021)

Destruction of ERP responses to deviance in an auditory oddball paradigm in amyloid infusion mice with memory deficits
por: Kim, Bowon, et al.
Publicado: (2020)

Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
por: Wang, Min Jeong, et al.
Publicado: (2017)

Erratum: Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
por: Yang, YoungSoon, et al.
Publicado: (2023)

Chemical‐Driven Outflow of Dissociated Amyloid Burden from Brain to Blood
por: Lee, Donghee, et al.
Publicado: (2022)

Rapid and sustained cognitive recovery in APP/PS1 transgenic mice by co-administration of EPPS and donepezil
por: Kim, Hye Yun, et al.
Publicado: (2016)

Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer’s Disease Therapeutics
por: Jeong, Hyomin, et al.
Publicado: (2022)

Chemical‐Driven Outflow of Dissociated Amyloid Burden from Brain to Blood (Adv. Sci. 12/2022)
por: Lee, Donghee, et al.
Publicado: (2022)

Abnormalities of plasma cytokines and spleen in senile APP/PS1/Tau transgenic mouse model
por: Yang, Seung-Hoon, et al.
Publicado: (2015)

Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity
por: Pyun, Jung-Min, et al.
Publicado: (2021)

Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer’s disease with PET imaging agents (18)F-flutemetamol and (18)F-florbetaben
por: Son, Hye Joo, et al.
Publicado: (2018)

Alterations of aqueous humor Aβ levels in Aβ-infused and transgenic mouse models of Alzheimer disease
por: Kwak, Da Eun, et al.
Publicado: (2020)

Bicine promotes rapid formation of β-sheet-rich amyloid-β fibrils
por: Kim, Hye Yun, et al.
Publicado: (2020)

Transgenic tomatoes expressing human beta-amyloid for use as a vaccine against Alzheimer’s disease
por: Youm, Jung Won, et al.
Publicado: (2008)

Prediction of amyloid PET positivity via machine learning algorithms trained with EDTA-based blood amyloid-β oligomerization data
por: Youn, Young Chul, et al.
Publicado: (2022)

Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ(42)
por: An, Seong Soo A., et al.
Publicado: (2017)

Solid-phase synthesis and pathological evaluation of pyroglutamate amyloid-β(3-42) peptide
por: Cho, Illhwan, et al.
Publicado: (2023)

The Cortical Neuroanatomy Related to Specific Neuropsychological Deficits in Alzheimer's Continuum
por: Kang, Sung Hoon, et al.
Publicado: (2019)

Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer’s disease mouse model
por: Kim, Shin Heun, et al.
Publicado: (2020)

Longitudinal profiling of oligomeric Aβ in human nasal discharge reflecting cognitive decline in probable Alzheimer’s disease
por: Yoo, Seung-Jun, et al.
Publicado: (2020)

The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an Alzheimer’s Disease-like Mouse Model
por: Kim, Juyong, et al.
Publicado: (2023)

NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease
por: Thatcher, Gregory RJ, et al.
Publicado: (2013)

Oligomerization by co-assembly of β-amyloid and α-synuclein
por: Kim, Jin Ryoun
Publicado: (2023)

Age-dependent inverse correlations in CSF and plasma amyloid-β(1–42) concentrations prior to amyloid plaque deposition in the brain of 3xTg-AD mice
por: Cho, Soo Min, et al.
Publicado: (2016)

SPG302 Reverses Synaptic and Cognitive Deficits Without Altering Amyloid or Tau Pathology in a Transgenic Model of Alzheimer’s Disease
por: Trujillo-Estrada, Laura, et al.
Publicado: (2021)

Plasmonic nanoparticle amyloid corona for screening Aβ oligomeric aggregate-degrading drugs
por: Lee, Dongtak, et al.
Publicado: (2021)

Adoptive therapy with amyloid-β specific regulatory T cells alleviates Alzheimer's disease
por: Yang, HyeJin, et al.
Publicado: (2022)

Clinical Implications of Amyloid-Beta Accumulation in Occipital Lobes in Alzheimer’s Continuum
por: Hwang, Jihye, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1m58apnuk3296vp7asc2q8qb8o